INTELLIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.76 USD | +3.70% |
|
-3.76% | -31.91% |
| Apr. 15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
| Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 23.82 | 26.08 | 32.66 |
| Spread/Res. | -12.85% | -20.40% | -36.44% |
| Spread/Supp. | +3.70% | +3.70% | +14.57% |
| Support | 20.02 | 20.02 | 18.12 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.
